Antiretroviral therapy coverage for PMTCT in Togo

Togo: Antiretroviral therapy coverage for PMTCT was 87.0% in 2024. ◆ Volatile

Latest (2024)
87.0%
Change on year
down 1.1%
World rank
33rd
of 84 countries
All-time high
98.0%
in 2016
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Togo, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 1 % of pregnant women living with HIV2004: 2 % of pregnant women living with HIV2005: 5 % of pregnant women living with HIV2006: 10 % of pregnant women living with HIV2007: 11 % of pregnant women living with HIV2008: 19 % of pregnant women living with HIV2009: 25 % of pregnant women living with HIV2010: 36 % of pregnant women living with HIV2011: 74 % of pregnant women living with HIV2012: 82 % of pregnant women living with HIV2013: 87 % of pregnant women living with HIV2014: 90 % of pregnant women living with HIV2015: 95 % of pregnant women living with HIV2016: 98 % of pregnant women living with HIV2017: 83 % of pregnant women living with HIV2018: 94 % of pregnant women living with HIV2019: 95 % of pregnant women living with HIV2020: 82 % of pregnant women living with HIV2021: 83 % of pregnant women living with HIV2022: 87 % of pregnant women living with HIV2023: 88 % of pregnant women living with HIV2024: 87 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Togo recorded 87.0% for antiretroviral therapy coverage for pmtct in 2024.

The figure is down 1.1% on the previous year and down 3.3% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Togo peaked at 98.0% in 2016 and was at its lowest, 0.0%, in 2000.

Togo ranks 33rd of 84 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Togo, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Togo, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 1.0%
2004 2.0% +100.0%
2005 5.0% +150.0%
2006 10.0% +100.0%
2007 11.0% +10.0%
2008 19.0% +72.7%
2009 25.0% +31.6%
2010 36.0% +44.0%
2011 74.0% +105.6%
2012 82.0% +10.8%
2013 87.0% +6.1%
2014 90.0% +3.4%
2015 95.0% +5.6%
2016 98.0% +3.2%
2017 83.0% -15.3%
2018 94.0% +13.3%
2019 95.0% +1.1%
2020 82.0% -13.7%
2021 83.0% +1.2%
2022 87.0% +4.8%
2023 88.0% +1.1%
2024 87.0% -1.1%

Togo compared with similar countries

  • Togo's 87.0% is above the median for lower middle income countries, which is 83.5%, 1.0× the median. (32 countries reporting)
  • Togo's 87.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.1× the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Togo changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +150.0% 2.0% 5.0%
2011 +105.6% 36.0% 74.0%
2004 +100.0% 1.0% 2.0%
2006 +100.0% 5.0% 10.0%
2008 +72.7% 11.0% 19.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 7.3% 0.0% 25.0% 10
2010s 83.4% 36.0% 98.0% 10
2020s 85.4% 82.0% 88.0% 5

Countries ranked near Togo

  1. 30 Cuba 89.0% compare
  2. 31 Cote d'Ivoire 88.0% compare
  3. 31 Liberia 88.0% compare
  4. 34 Panama 86.0% compare
  5. 35 Ecuador 85.0% compare
  6. 35 Vietnam 85.0% compare

See the full ranking of 99 places →

More health data for Togo

All data for Togo →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Togo?
Antiretroviral therapy coverage for pmtct in Togo was 87.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Togo?
The highest recorded value was 98.0% in 2016.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Togo?
The lowest recorded value was 0.0% in 2000.
How does Togo rank for antiretroviral therapy coverage for pmtct?
Togo ranks 33rd out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Togo?
Over the last ten years it is down 3.3%. The long-run trend across the full record is volatile.
Where does this Togo data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Togo. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/togo/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/togo/">Antiretroviral therapy coverage for PMTCT in Togo</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).